Fundraising FoxSmilegate Investment — 2025 Investments
7 investments dated 2025 · listed companies and verified rows first · show all
Appcharge offers a checkout product built for direct-to-consumer payments in gaming, supporting iOS payment links, side-loaded apps, and browser games.
FintechGamingSaaS
Maor Sason(Founder)inRoei Barassi(Founder)in
Co-investorsBitkraft Esports VenturesGlilot Capital PartnersIVP (Institutional Venture Partners)Moneta VCPlay VenturesCreandum+3 more
Cuckoo is a broadband provider offering full fibre internet to consumers, positioning itself on simpler pricing, fairer deals and customer service.
Consumer
Tommy Toner(Founder)in
Co-investorsRTP GlobalBonAngels Venture PartnersMashup VenturesSchmidtY Combinator
Cuckoo is an AI-powered real-time translator that works within video conferencing, chat, and communication platforms to enable multilingual conversations for global teams.
AI & Machine LearningEnterprise SoftwareSaaSSeoul, KR
Yong Hee Lee(COO)inGunwoo Kim(CEO)in
Co-investorsSchmidtY CombinatorBass InvestmentBonAngels Venture PartnersMashup VenturesSAV (Scale Asia Ventures)+1 more
EGONGEGONG (이공이공) is a North American distribution and brand accelerator that sources Korean consumer products, launches them on Amazon and across US retail, and invests directly in the brands it grows.
ConsumerE-commerceRetail Tech
Co-investorsLaguna InvestmentLotte VenturesSolidus InvestmentKorea Investment Partners
HabitFactory provides tools that support the insurance workflow from consultation to contract completion, and helps users through loan processes by reducing paperwork and interest-rate comparison using AI-based tools and expert consultation.
AI & Machine LearningFintechInsurTech
Co-investorsWe VenturesZ Venture CapitalKB InvestmentKolon Investment, Inc.Korea Development BankShinhan Venture Investment
Pine Tree Therapeutics develops therapies based on targeted protein degradation, with a focus on addressing drug resistance.
BiotechCambridge, US
Ho-Juhn Song(Founder)Ho-Juhn Song, Ph.D(Co-Founder & Chief Executive Officer)
Co-investorsAtinum Investment Co. Ltd.DSC InvestmentKorea Investment PartnersSchmidtSTIC InvestmentsSTIC Ventures
Prazer Therapeutics develops therapeutics using Targeted Protein Degradation (TPD) technology, including its SPiDEM platform, in which small molecules selectively bind pathological proteins and activate the ubiquitin-proteasome system for their elimination.
BiotechDeep TechSeoul, KR
Co-investorsKiwoom InvestmentCompany K PartnersPremier Partners
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.